{"schema_version":"secwatch.filing_event.v1","accession":"0001380106-26-000007","form_type":"8-K","ticker":"RPID","cik":"0001380106","company_name":"RAPID MICRO BIOSYSTEMS, INC.","filed_at":"2026-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.951997+00:00","generated_at":"2026-05-16T10:38:30.838587+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Rapid Micro Biosystems pre-announces record Q4 rev $11.3M (+37% YoY); FY rev $33.6M (+20%)","bullets":["Q4 2025 total revenue expected ~$11.3M, up ~37% YoY; record multi-system order from Top 20 biopharma customer.","Full year 2025 revenue expected ~$33.6M, up ~20% YoY; recurring revenue $17.8M (+15%).","Q4 placed 16 new Growth Direct systems, validated 3 customer systems; full year placed 28 and validated 18.","Cumulative installed base: 190 systems globally, 155 validated.","Company to announce complete FY2025 results and 2026 outlook later in Q1 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001380106-26-000007","json":"https://secwatch.observer/filing/0001380106-26-000007.json","markdown":"https://secwatch.observer/filing/0001380106-26-000007.md","text":"https://secwatch.observer/filing/0001380106-26-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1380106/000138010626000007/0001380106-26-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1380106/000138010626000007/rpid-20260113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:38:30.838587+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}